Providers value functionality in advanced viz software

Two-thirds of surveyed providers would consider using their advanced visualization system as their primary reading environment as a way of consolidating vendors, according to the report “Advanced Visualization 2013: How Advanced Is It?” from market research firm KLAS.

This desire to consolidate would seem to benefit advanced visualization system vendors like Siemens, GE and Philips who are also modality suppliers, according to the report’s executive summary. Providers who did not wish to use the software as a reading environment indicated advanced visualization systems don’t offer the same functionality as the PACS workflow they currently use.

The report also showed that cardiac, vascular and neurology are the most critical areas for the use of advanced visualization software in the eyes of providers.

Breaking down the different vendors, Vital ranked as one of the top two vendors in all three of the most critical areas, while other vendors had more variable results. Philips, for example, ranked No. 1 in neurology and rated highly in cardiac imaging, but came in fifth for vascular imaging. TeraRecon was one of the leaders in the vascular space, but lagged behind in cardiac and neurology.

Providers also indicated that high functionality and a positive purchasing experience don’t necessarily go hand-in-hand. Despite scoring top marks for functionality in all but one area, Vital was fourth out of five for sales experience, according to KLAS.

GE and Philips clocked in as the vendors with the most user-friendly advanced visualization systems.

Evan Godt
Evan Godt, Writer

Evan joined TriMed in 2011, writing primarily for Health Imaging. Prior to diving into medical journalism, Evan worked for the Nine Network of Public Media in St. Louis. He also has worked in public relations and education. Evan studied journalism at the University of Missouri, with an emphasis on broadcast media.

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.